CASI Pharmaceuticals's total assets for Q3 2024 were $63.62M, an increase of 19.38% from the previous quarter. CASI total liabilities were $49.77M for the fiscal quarter, a 17.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.